§ 13F · FUND PROFILE
Catalio Capital Management, LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 45Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$565.8T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | GILD | GILEAD SCIENCES INC | 289K | $35.5T | 6.3% | NEW |
| 2 | BMY | BRISTOL-MYERS SQUIBB CO | 648K | $34.9T | 6.2% | NEW |
| 3 | BSX | BOSTON SCIENTIFIC CORP | 360K | $34.4T | 6.1% | NEW |
| 4 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 411K | $31.4T | 5.6% | NEW |
| 5 | LLY | ELI LILLY & CO | 26K | $27.9T | 4.9% | NEW |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | 654K | $26.9T | 4.8% | NEW |
| 7 | ASND | ASCENDIS PHARMA A/S | 119K | $25.4T | 4.5% | NEW |
| 8 | SNDX | SYNDAX PHARMACEUTICALS INC | 1.20M | $25.1T | 4.4% | NEW |
| 9 | JNJ | JOHNSON & JOHNSON | 121K | $25.0T | 4.4% | NEW |
| 10 | REGN | REGENERON PHARMACEUTICALS | 30K | $23.0T | 4.1% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE CATALIO SIGNAL
AC read
Catalio Capital Management, LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed